BPTSY
Price
$1.73
Change
+$0.03 (+1.76%)
Updated
May 23 closing price
Capitalization
3.04M
NGNE
Price
$21.80
Change
-$1.12 (-4.89%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
311.34M
Interact to see
Advertisement

BPTSY vs NGNE

Header iconBPTSY vs NGNE Comparison
Open Charts BPTSY vs NGNEBanner chart's image
Biophytis SA
Price$1.73
Change+$0.03 (+1.76%)
Volume$1.05K
Capitalization3.04M
Neurogene
Price$21.80
Change-$1.12 (-4.89%)
Volume$4.37K
Capitalization311.34M
BPTSY vs NGNE Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPTSY vs. NGNE commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTSY is a Hold and NGNE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BPTSY: $1.73 vs. NGNE: $22.97)
Brand notoriety: BPTSY and NGNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPTSY: 250% vs. NGNE: 108%
Market capitalization -- BPTSY: $3.04M vs. NGNE: $311.34M
BPTSY [@Biotechnology] is valued at $3.04M. NGNE’s [@Biotechnology] market capitalization is $311.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPTSY’s FA Score shows that 1 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • BPTSY’s FA Score: 1 green, 4 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, both BPTSY and NGNE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 6 TA indicator(s) are bullish.

  • NGNE’s TA Score: 6 bullish, 4 bearish.

Price Growth

BPTSY (@Biotechnology) experienced а 0.00% price change this week, while NGNE (@Biotechnology) price change was +22.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

NGNE is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($311M) has a higher market cap than BPTSY($3.04M). NGNE YTD gains are higher at: 0.481 vs. BPTSY (-44.013). BPTSY has higher annual earnings (EBITDA): -15.13M vs. NGNE (-77.68M). NGNE has higher revenues than BPTSY: NGNE (925K) vs BPTSY (0).
BPTSYNGNEBPTSY / NGNE
Capitalization3.04M311M1%
EBITDA-15.13M-77.68M19%
Gain YTD-44.0130.481-9,147%
P/E RatioN/AN/A-
Revenue0925K-
Total CashN/A293M-
Total DebtN/A13.5M-
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBICX10.18N/A
N/A
DWS Global Macro C
MVEIX10.52N/A
N/A
Monteagle Select Value I
TRLCX22.74N/A
N/A
Nuveen Large Cap Value Retire
OCSVX10.10N/A
N/A
Optimum Small-Mid Cap Value C
RTOUX38.95N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap M

BPTSY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPTSY has been closely correlated with CDTX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if BPTSY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTSY
1D Price
Change %
BPTSY100%
N/A
CDTX - BPTSY
92%
Closely correlated
N/A
NGNE - BPTSY
38%
Loosely correlated
+6.00%
RNAZ - BPTSY
36%
Loosely correlated
-1.89%
VRCA - BPTSY
27%
Poorly correlated
-2.10%
BRNS - BPTSY
26%
Poorly correlated
-8.33%
More

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+6.00%
BRNS - NGNE
51%
Loosely correlated
-8.33%
RNAZ - NGNE
48%
Loosely correlated
-1.89%
ZNTL - NGNE
47%
Loosely correlated
-2.00%
SNDX - NGNE
45%
Loosely correlated
+1.82%
IRON - NGNE
43%
Loosely correlated
+1.39%
More